Search Clinical Trials
583,492 trials
ID
Status
Phase
Title
Sponsor
NCT07573540
Optimizing Smart Technology for Addiction RecoveryNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Not Yet RecruitingNot Applicable
NCT07573540Not Yet Recruiting
Not Applicable
Optimizing Smart Technology for Addiction RecoveryNational Institute on Alc...
NCT07573111
Open-label, Single Ascending Dose Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell TransplantationLaguna Biotherapeutics, Inc.Not Yet RecruitingPhase 1
NCT07573111Not Yet Recruiting
Phase 1
Open-label, Single Ascending Dose Study of QUAIL-100 in Pediatric and Young Adul...Laguna Biotherapeutics, I...
NCT07573670
A Phase 2 Study of Bcl-2 Inhibitor Combined With Azacitidine for Newly Diagnosed Mixed Phenotype Acute LeukemiaThe First Affiliated Hospital of Soochow UniversityNot Yet RecruitingPhase 2
NCT07573670Not Yet Recruiting
Phase 2
A Phase 2 Study of Bcl-2 Inhibitor Combined With Azacitidine for Newly Diagnosed...The First Affiliated Hosp...
NCT07573631
An Open-Label Extension Study to Evaluate the Long-term Safety and Efficacy of BMN 351 in Participants With Duchenne Muscular DystrophyBioMarin PharmaceuticalEnrolling By InvitationPhase 2
NCT07573631Enrolling By Invitation
Phase 2
An Open-Label Extension Study to Evaluate the Long-term Safety and Efficacy of B...BioMarin Pharmaceutical
NCT07573163
Tirzepatide Following Adrenalectomy in Mild Autonomous Cortisol SecretionAlaa SadaNot Yet RecruitingPhase 2
NCT07573163Not Yet Recruiting
Phase 2
Tirzepatide Following Adrenalectomy in Mild Autonomous Cortisol SecretionAlaa Sada
NCT07574047
MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for Advanced Melanoma.Swiss Cancer InstituteNot Yet RecruitingPhase 4
NCT07574047Not Yet Recruiting
Phase 4
MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for...Swiss Cancer Institute
NCT07573332
A Safety and Tolerability Study of CC- 97540 (BMS-086353) in Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica PatientsBristol-Myers SquibbNot Yet RecruitingPhase 1
NCT07573332Not Yet Recruiting
Phase 1
A Safety and Tolerability Study of CC- 97540 (BMS-086353) in Anti-Aquaporin 4 An...Bristol-Myers Squibb
NCT07572461
A Single-Arm, Prospective Study of Papaverine for the Treatment of Refractory Peripheral Neuropathy Induced by Taxane-Based ChemotherapySecond Affiliated Hospital, School of Medicine, Zhejiang UniversityNot Yet RecruitingNot Applicable
NCT07572461Not Yet Recruiting
Not Applicable
A Single-Arm, Prospective Study of Papaverine for the Treatment of Refractory Pe...Second Affiliated Hospita...
NCT07573267
Effects of Myofascial Release, Dynamic and Static Stretching in Adolescent Karate AthletesIstinye UniversityCompletedNot Applicable
NCT07573267Completed
Not Applicable
Effects of Myofascial Release, Dynamic and Static Stretching in Adolescent Karat...Istinye University
NCT07574307
Kinesiotaping in Isolated Meniscus InjuriesBandırma Onyedi Eylül UniversityRecruitingNot Applicable
NCT07574307Recruiting
Not Applicable
Kinesiotaping in Isolated Meniscus InjuriesBandırma Onyedi Eylül Uni...
NCT07573241
Single Arm Trial Identifying Barriers and Facilitators to Mindfulness PracticeNational Center for Complementary and Integrative Health (NCCIH)Not Yet RecruitingNot Applicable
NCT07573241Not Yet Recruiting
Not Applicable
Single Arm Trial Identifying Barriers and Facilitators to Mindfulness PracticeNational Center for Compl...
NCT07571954
Evaluation of iNstroke 5F Aspiration Catheters for Thrombectomy: a Multi-center Prospective StudyiVascular S.L.U.Not Yet RecruitingNot Applicable
NCT07571954Not Yet Recruiting
Not Applicable
Evaluation of iNstroke 5F Aspiration Catheters for Thrombectomy: a Multi-center...iVascular S.L.U.
NCT07573436
Loncastuximab Tesirine and Rituximab as First-line Therapy in Patients With Post-transplant Lymphoproliferative Disorder (PLUTO)ADC Therapeutics S.A.Not Yet RecruitingPhase 1
NCT07573436Not Yet Recruiting
Phase 1
Loncastuximab Tesirine and Rituximab as First-line Therapy in Patients With Post...ADC Therapeutics S.A.
NCT07573150
Pupillometry in Identifying Risk of Postoperative Opioid-induced Respiratory Depression in Children Undergoing TonsillectomyNational Institute on Drug Abuse (NIDA)Not Yet Recruiting
NCT07573150Not Yet Recruiting
—
Pupillometry in Identifying Risk of Postoperative Opioid-induced Respiratory Dep...National Institute on Dru...
NCT07573748
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospital of Huai'anNot Yet RecruitingNot Applicable
NCT07573748Not Yet Recruiting
Not Applicable
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospi...
NCT07574320
Effect of Ramosetron in Patients With Diarrhea Predominant Irritable Bowel SyndromeMd. Aminul IslamNot Yet RecruitingPhase 4
NCT07574320Not Yet Recruiting
Phase 4
Effect of Ramosetron in Patients With Diarrhea Predominant Irritable Bowel Syndr...Md. Aminul Islam
NCT07573722
Neck Exercises for Improving Pelvic Alignment and Low Back PainYuanpei University of Medical TechnologyCompletedNot Applicable
NCT07573722Completed
Not Applicable
Neck Exercises for Improving Pelvic Alignment and Low Back PainYuanpei University of Med...
NCT07574281
Effectiveness and Implementation of the DINKNESH Digital Palliative Care Tool in EthiopiaAddis Ababa UniversityNot Yet RecruitingNot Applicable
NCT07574281Not Yet Recruiting
Not Applicable
Effectiveness and Implementation of the DINKNESH Digital Palliative Care Tool in...Addis Ababa University
NCT07573904
Comparative Effects of Posture Correction Exercises and Papworth Technique in Asthmatic Forward Head PostureRiphah International UniversityCompletedNot Applicable
NCT07573904Completed
Not Applicable
Comparative Effects of Posture Correction Exercises and Papworth Technique in As...Riphah International Univ...
Result Breakdown
Not yet recruiting15 (75%)
Completed3 (15%)
Enrolling by invitation1 (5%)
Recruiting1 (5%)
not_applicable11 (55%)
Phase 13 (15%)
Phase 23 (15%)
Phase 42 (10%)
Not Specified1 (5%)